# Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

> **NCT01907763** · PHASE3 · TERMINATED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 194 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SOTB07 200mg
- **DRUG:** SOTB07 400mg
- **DRUG:** SOTB 200mg placebo
- **DRUG:** SOTB 400mg placebo

## Key facts

- **NCT ID:** NCT01907763
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01907763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01907763, "Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01907763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*